Efficacy, safety, and tolerance of piperacillin/tazobactam compared to co-amoxiclav plus an aminoglycoside in the treatment of severe pneumonia

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 17, Issue 5, 1998, Pages 313-317

  Speich, R ^a   Imhof, E ^b   Vogt, M ^c   Grossenbacher, M ^d   Zimmerli, W ^e  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b TRIEMLI HOSPITAL   (Switzerland)

^c KANTONSSPITAL   (Switzerland)

^d CANTONAL HOSPITAL AARAU   (Switzerland)

^e UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; GENTAMICIN; NETILMICIN; PIPERACILLIN PLUS TAZOBACTAM;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FEVER; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FAILURE; LIVER TOXICITY; MAJOR CLINICAL STUDY; MORTALITY; MULTICENTER STUDY; PNEUMONIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0031848899     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01709453     Document Type: Article

References (13)

1. Winston DJ, Murphy W, Young LS, Hewitt WL: Piperacillin therapy for serious bacterial infections. American Journal of Medicine (1980) 69:255-261
2. Gooding PG, Clark BJ, Sathe SS: Piperacillin: review of clinical experience. Journal of Antimicrobial Chemotherapy (1982) 9, Supplement B: 93-99
3. Mouton Y, Beuscart C, Soussy C: Efficacité et tolérance de la pipéracilline chez 333 malades. Presse Médicale (1986) 15:2347-2350
4. Philippon A, Paul G, Nevot P: Beta-lactamases. Incidences et intérêt clinique. Réanimation, Soins Intensifs et Médecine d'Urgence (1987) 3:229-237
5. Kuck NA, Jacobus NV, Petersen PJ, Weiss WJ, Testa RT: Comparative in vitro and in vivo activities of piperacillin combined with beta-lactamase inhibitors tazobactam, clavulanic acid and sulbactam. Antimicrobial Agents and Chemotherapy (1989) 33:1964-1969
6. Gutmann L, Kitzis M-D, Yamabe A, Acar JF: Comparative evaluation of a new β-lactamase inhibitor, YTR 830, combined with different β-lactam antibiotics against bacteria harbouring known β-lactamases. Antimicrobial Agents and Chemotherapy (1986) 29:955-957
7. Moellering RC: Meeting the challenges of β-lactamases. Journal of Antimicrobial Chemotherapy (1993) 31:1-8
8. Mouton Y, Leroy O, Beuscart C, Chidiac C, Senneville E, Ajana F, Lecoq P, and Study Group: Efficacy, safety and tolerance of parenteral piperacillin/tazobactam in the treatment of patients with lower respiratory tract infections. Journal of Antimicrobial Chemotherapy (1993) 31, Supplement A: 87-95
9. Sifunetes-Osornio J, Ruiz-Palacios GM, Jakob E, Rojas JJ, Jauregui A, Villalobos Y: Piperacillin/tazobactam in the treatment of lower respiratory tract infections: an open non-comparative and multicentered trial. Journal of Chemotherapy (1994) 6:197-203
10. Bauernfeind A, Schweighart S, Eberlein E, Jungwirth R: In vitro activity and stability against novel beta-lactamases of investigational beta-lactams (cefepime, cefpirome, flomoxef, SCE2787 and piperacillin plus tazobactam) in comparison with established compounds (cefotaxime, latamoxef and piperacillin). Infection (1991) 19, Supplement 5:264-275
11. Bourgault AM, Lamonthe F, Hoban DJ, Dalton MT, Kibsey PC, Harding G, Smith JA, Low DE, Gilbert H : Survey of Bacteroides fragilis group susceptibility patterns in Canada. Antimicrobial Agents and Chemotherapy (1992) 36:343-347
12. Dornbusch K, Mortsell E, Goransson E: In vitro activity of cefepime, a new parenteral cephalosporin, against recent European blood isolates and in comparison with piperacillin/tazobactam. Chemotherapy (1990) 36:259-267
13. Jones RN, Pfaller MA, Fuchs PC, Aldridge K, Allen SD. Gerlach EH: Piperacillin/tazobactam (YTR 830) combination. Comparative antimicrobial activity against 5889 recent aerobic clinical isolates and 60 Bacteroides fragilis group strains. Diagnostic Microbiology and Infectious Disease (1989) 12:489-494